Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...

I started future-proofing in my mid-40s. I knew menopause was coming, and I needed some way to have the upper hand—to pretend I had control over the inevitable outcome of aging in a female body. It ...

Structured behavioral therapy focused on pelvic floor muscle exercise was noninferior to treatment with solifenacin for alleviating overactive bladder symptoms in patients with Parkinson’s disease (PD ...

Dr. Keith Roach, M.D. DEAR DR. ROACH: My daughter, who is 50, recently went to a urologist for bladder retention issues. She had several tests performed. My daughter’s doctor told her that the ...

You’re out running errands when the sudden urge to use the bathroom overcomes you. Unable to ignore the feeling, you begin searching for the nearest bathroom. Will you make it in time to avoid an ...

Vivally ® System, wearable closed-loop neuromodulation system and mobile application for urge incontinence and urinary urge, recognized by MedTech Breakthrough Awards program for 2023 COLUMBUS, Ohio, ...

This article was reviewed by Julia Switzer, MD, FACOG. Urinary incontinence is the term for a loss of bladder control. In ...

Pelvic floor therapy is often only associated with women who experience pelvic floor dysfunction after childbirth, but men can also benefit from this treatment. Working with a pelvic floor physical ...

(BPT) - It was the everyday struggles that really got to Peggy Smith. Smith couldn’t even make it to the grocery store without stopping to find a bathroom, let alone enjoy activities with her family ...

NEW YORK (Reuters Health) - Postmenopausal women who take estrogen for years are more likely to experience incontinence than those on the hormone for a shorter time or not at all, a new study finds.

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...

The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the ...